当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Nature Reviews Clinical Oncology杂志
Nature Reviews Clinical Oncology
基本信息
期刊名称 Nature Reviews Clinical Oncology
NAT REV CLIN ONCOL
期刊ISSN 1759-4774
期刊官方网站 https://www.nature.com/nrclinonc
是否OA No
出版商 Nature Publishing Group
出版周期 Monthly
文章处理费 登录后查看
始发年份 2009
年文章数 51
影响因子 81.1(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 ONCOLOGY 肿瘤学1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 99.4 21.048 10.846
Medicine
Oncology
3/404 99%
补充信息
自引率 0.6%
H-index 127
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-4774%5BISSN%5D
投稿指南
期刊投稿网址 https://mts-nrclinonc.nature.com/
收稿范围
Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.

In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.

Subjects Covered
Chemotherapy
Clinical pharmacology
Diagnosis
Epidemiology
Experimental therapies
Genetics
Health services, economics and outcomes research
Hematology
Hormonal therapies
Imaging
Immunotherapy
Medical oncology
Palliative care
Pathology
Pediatric oncology
Prevention
Radiotherapy
Screening
Signal transduction
Statistics
Surgical oncology
Targeted therapies
收录体裁
Review, Perspective, News & Views articles, Research Highlights
投稿指南 https://www.nature.com/nrclinonc/for-authors
投稿模板
参考文献格式 https://www.nature.com/nrclinonc/for-authors/preparing-your-submission
编辑信息

Chief Editor: Diana Romero, BSc, PhD ORCiD

Diana obtained her PhD in Biochemistry from the Universidad Autonoma de Madrid (Spain), where she studied the role of TGF-β in cancer progression in Miguel Quintanilla's group. She joined Calvin Vary's laboratory at Maine Medical Center Research Institute (US) for her first postdoctoral project, which was related to TGF-β receptor signalling and prostate cancer. In 2010 she moved to Robert Kypta's group at Imperial College London (UK) as a postdoc. While maintaining her interest in prostate cancer, her project focused on Dickkopf-3 signalling. Diana joined the Nature Reviews Clinical Oncology team in July 2015, and became Chief Editor of the journal in September 2017.

Diana is based in the London office.

Senior Editor: David Killock, BSc, ARCS, PhD ORCiD

David obtained a BSc in Biochemistry from the Imperial College London. His undergraduate studies included a 1-year sandwich placement working in a GlaxoSmithKline drug metabolism and pharmacokinetics laboratory focused on metabolite identification. Subsequently, David became a Research Assistant working within the Membrane/Cytoskeletal Signalling Group of the National Heart and Lung Institute Cardiovascular Sciences Department, Imperial College London, and went on to conduct a PhD focused on mechanisms of leukocyte trafficking, under the guidance of Dr Aleksandar Ivetic. After moving with Dr Ivetic to King's College London Cardiovascular Division in 2009, David conducted a short post-doctoral project before moving out of the laboratory and into medical publishing as a Locum Associate Editor at Nature Reviews Rheumatology. Since joining Nature Reviews, he has worked on other titles, including Nature Reviews Urology. He joined the Nature Reviews Clinical Oncology team in 2014, where he was promoted to Senior Editor in 2016.

David is based in the London office.

Senior Editor: Peter Sidaway, BSc, PhD ORCiD

After studying pharmacology at the University of Newcastle Upon Tyne, UK, Peter commenced his doctoral studies in retinal neuroscience at the University of East Anglia, UK. After obtaining his PhD, he moved to the University of Birmingham, UK, where he became interested in autonomic neuroscience and neuropharmacology relating to the control of pelvic organ function. Peter further pursued these research interests as a Japan Society for the Promotion of Science overseas research fellow, before joining Nature Clinical Reviews as a Cross-Title Associate Editor in April 2014. He worked as an Associate Editor shared between Nature Reviews Urology and Nature Reviews Clinical Oncology. From November 2017, he is a Senior Editor for Nature Reviews Clinical Oncology.

Peter is based in the Berlin office.

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug